IceCure Medical Ltd.

ICCM Nasdaq CIK: 0001584371

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type other
SEC Category Non-accelerated filerEmerging growth company
State of Incorporation Israel
Country Israel
Business Address 7 HA'ESHEL ST., POB 3163, CAESAREA, , 38900
Mailing Address 7 HA'ESHEL ST., POB 3163, CAESAREA, , 38900
Phone 972-4-6230333
Fiscal Year End 1231
EIN 000000000

Recent SEC Filings

Form Type Date Filed Document
F-1 Foreign company IPO registration April 1, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment March 27, 2026 View on SEC
424B5 Prospectus supplement March 27, 2026 View on SEC
6-K Foreign company current report March 27, 2026 View on SEC
3 Initial insider ownership report March 25, 2026 View on SEC
3 Initial insider ownership report March 25, 2026 View on SEC
3 Initial insider ownership report March 25, 2026 View on SEC
3 Initial insider ownership report March 25, 2026 View on SEC
3 Initial insider ownership report March 25, 2026 View on SEC
3 Initial insider ownership report March 25, 2026 View on SEC

Annual Reports

20-F March 17, 2026
  • Groundbreaking FDA marketing authorization for ProSense to treat low-risk breast cancer in specific patient groups (October 3, 2025).
  • ProSense holds broader regulatory approvals (FDA 510(k), CE Mark) for lung, kidney, and bone tumors, with global reach in 27 countries.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.